# The AIM Study: Assessing the Impact of Margin Reduction

> **NCT00754000** · — · COMPLETED · sponsor: **Varian, a Siemens Healthineers Company** · enrollment: 82 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** Observation

## Key facts

- **NCT ID:** NCT00754000
- **Lead sponsor:** Varian, a Siemens Healthineers Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** —
- **Final completion:** 2009-09
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2012-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00754000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00754000, "The AIM Study: Assessing the Impact of Margin Reduction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00754000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*